US Executive Compensation Proxy SEC Filings — March 09, 2026

09-03-2026

American Resources Corporation (AREC) filed its 2026 DEF 14A Proxy Statement for the Annual Shareholder Meeting on April 15, 2026, seeking shareholder approval to elect its five current director nominees for one-year terms and to ratify GreenGrowth CPAs as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is February 17, 2026, with 106,925,819 shares of common stock outstanding. The Board unanimously recommends voting FOR both proposals, with no financial performance metrics or period-over-period comparisons disclosed in the filing.

• ·Annual Meeting location: 12115 Visionary Way, Suite 174, Fishers, Indiana 46038; in-person only, no virtual participation option.
• ·Board Diversity (as of January 1, 2026): 1 female, 4 male directors; 1 Hispanic or Latinx director.
• ·Voting methods: Internet at www.AALvote.com/AREC or www.FCRvote.com/AREC, telephone at 1-866-804-9619, mail, or in-person.
• ·Directors elected by plurality vote; abstentions and broker non-votes do not affect outcome.

09-03-2026

PharmaCyte Biotech, Inc. (PMCB) filed a DEF 14A proxy statement on March 9, 2026, for its virtual annual stockholder meeting on March 30, 2026, at 11:00 a.m. ET, with record date January 30, 2026. As of the record date, 10,735,649 common shares were outstanding, plus 2,677,093 as-converted votes from Series C Preferred Stock. The filing includes pay versus performance disclosures for executives Joshua N. Silverman and Kenneth L. Waggoner covering fiscal years ended April 30, 2023, 2024, and 2025, though specific compensation values are not detailed in the provided content.

• ·Annual meeting held virtually; access via http://www.web.viewproxy.com/PMCB/2026
• ·Fiscal year end: April 30
• ·Transfer agent: Equiniti Trust Company, LLC
• ·Business address: 3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV 89169

09-03-2026

This DEF 14A proxy statement seeks shareholder approval for an Extension Amendment to extend the SPAC's business combination deadline beyond March 16, 2026, avoiding liquidation, with the Trust Account holding $1.88M or $12.06 per public share as of the March 6, 2026 Record Date. The Sponsor controls 98.2% of voting power with 4,325,000 Class B shares and 430,000 Preference Shares, ensuring approval despite only 155,614 public Class A shares outstanding and no exchange listing, which limits liquidity. While the extension provides more time for the Proposed Business Combination, it marks the fifth such extension since the 2021 IPO, highlighting ongoing delays and risks of warrant expiration and potential per-share distributions below $10.00 in liquidation.

• ·Redemption election deadline: 5:00 p.m. ET on March 12, 2026 (two business days prior to meeting)
• ·Current Combination Period deadline: March 16, 2026 (60 months post-IPO closing on March 16, 2021)
• ·Voting requirements: Extension needs 2/3 affirmative votes; Adjournment needs simple majority
• ·Preference Shares purchased by Sponsor on February 13, 2026 at par value
• ·Warrants expire worthless if no business combination by March 16, 2026

09-03-2026

The proxy statement solicits votes for the annual shareholder meetings of five Flaherty & Crumrine closed-end funds (PFD, PFO, FFC, FLC, DFP) on April 15, 2026, primarily to elect directors, with a record date of January 15, 2026. As of the record date, total shares outstanding ranged from 10.5M for FLC to 48.2M for FFC. Cede & Co. holds nearly 100% record ownership across all funds, while other beneficial owners exceed 5% in specific funds including Sit Investment Associates (up to 10.4% in FLC) and First Trust entities (5.65% in FFC).

• ·Directors and officers own less than 1% of shares in each fund as of January 15, 2026.
• ·Annual reports with audited financials for fiscal year ended November 30, 2025 available on www.preferredincome.com or via Computershare.
• ·Meetings require majority quorum; may be adjourned up to 120 days if needed.

09-03-2026

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated (FFC) and four affiliated funds (PFD, PFO, FLC, DFP) issued a joint definitive proxy statement for annual shareholder meetings on April 15, 2026, at 8:00 a.m. PDT, primarily to elect directors, with a record date of January 15, 2026. FFC had 48,177,896 shares outstanding, while ownership was highly concentrated with Cede & Co. as record holder of 99.93%; beneficial ownership exceeded 5% for entities like First Trust Portfolios L.P. (5.65% in FFC). Directors and officers owned less than 1% across all funds, with no other significant changes or performance metrics disclosed.

• ·Record date for voting: January 15, 2026
• ·Annual meetings location: 301 E. Colorado Boulevard, Suite 800, Pasadena, CA 91101
• ·Fiscal year end: November 30; annual reports available for year ended November 30, 2025
• ·Directors and officers own less than 1% of shares in each fund
• ·Quorum requires majority of outstanding shares; meetings may be adjourned up to 120 days if needed

09-03-2026

The Joint Proxy Statement solicits votes for the Annual Meetings of Shareholders on April 15, 2026, for Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated (PFO, NYSE: PFO) and four other funds (PFD, FFC, FLC, DFP), primarily to elect Directors (Proposal 1). Record date is January 15, 2026, with PFO having 13,077,326 shares outstanding; major record holder Cede & Co. owns 98.09% of PFO shares, while Sit Investment Associates beneficially owns 10.20%. No other proposals are specified, and directors/officers own less than 1% of shares across funds.

• ·Annual Meetings at 8:00 a.m. PDT, 301 E. Colorado Boulevard, Suite 800, Pasadena, CA 91101.
• ·Quorum requires majority of outstanding shares; may adjourn up to 120 days if needed.
• ·Directors and officers own less than 1% of shares in each fund as of record date.

09-03-2026

Flaherty & Crumrine Dynamic Preferred & Income Fund Inc (DFP) and four affiliated funds (PFD, PFO, FFC, FLC) have issued a joint proxy statement for their annual shareholder meetings on April 15, 2026, primarily to elect directors, with record date January 15, 2026. As of the record date, DFP had 20,538,137 shares outstanding, with Cede & Co. holding a record 99.97% and Raymond James & Associates beneficially owning 5.60%. No other material financial metrics or performance changes are disclosed in the filing.

• ·Annual meetings held at 301 E. Colorado Boulevard, Suite 800, Pasadena, CA 91101.
• ·Directors and officers own less than 1% of shares in each fund as of January 15, 2026.
• ·Fiscal year ended November 30, 2025; annual reports available on www.preferredincome.com or SEC website.

09-03-2026

This joint DEF 14A proxy statement for Flaherty & Crumrine Total Return Fund Inc. (FLC) and four affiliated funds (PFD, PFO, FFC, DFP) solicits votes for annual shareholder meetings on April 15, 2026, to elect directors, with a record date of January 15, 2026. As of the record date, FLC had 10,456,821 shares outstanding, with Cede & Co. as record owner of 99.91% and Sit Investment Associates beneficially owning 10.40%; directors and officers own less than 1%. Annual reports with audited financials for the fiscal year ended November 30, 2025, are available online, but no performance metrics are detailed in the proxy.

• ·Meetings held at 301 E. Colorado Boulevard, Suite 800, Pasadena, CA 91101 at 8:00 a.m. PDT on April 15, 2026.
• ·Proxy materials mailed on or about March 9, 2026.
• ·Cede & Co. record ownership percentages: PFD 98.88%, PFO 98.09%, FFC 99.93%, DFP 99.97%.
• ·Other major beneficial owners: First Trust group 5.65% of FFC; Raymond James & Associates 5.60% of DFP; Sit Investment PFD 8.40%, PFO 10.20%.

09-03-2026

Western Asset High Income Opportunity Fund Inc. (NYSE: HIO) has issued a proxy statement for its Annual Meeting of Stockholders on April 17, 2026, to elect three Class I Directors (Proposal 1) and ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending September 30, 2026 (Proposal 2). The record date is February 6, 2026, with 95,099,215 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Meeting location: One Madison Avenue, 17th Floor, New York, New York 10010 at 10:00 a.m. New York time
• ·Quorum requires majority of outstanding shares present in person or by proxy
• ·Fund subject to Maryland Control Share Acquisition Act (MCSAA) with certain exemptions

09-03-2026

Western Asset Intermediate Muni Fund Inc. (NYSE: SBI) issued a definitive proxy statement for its Annual Meeting of Stockholders on April 17, 2026, seeking approval to elect two Class III Directors and ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ended November 30, 2026. The record date is February 6, 2026, with 14,082,315 shares of common stock and 1,896 shares of variable rate demand preferred stock (VRDPS) outstanding at that date. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Quorum requires majority of outstanding common and preferred shares voting together as a single class.
• ·Annual reports available upon request or via www.franklintempleton.com/investments/options/closed-end-funds and SEC EDGAR.

09-03-2026

Western Asset Investment Grade Opportunity Trust Inc. (NYSE: IGI) issued a definitive proxy statement for its Annual Meeting of Stockholders on April 17, 2026, to elect three Class II Directors and ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending November 30, 2026. The record date is February 6, 2026, with 5,993,650 shares of common stock outstanding. No financial performance metrics or period-over-period comparisons are disclosed in the filing.

• ·Annual Meeting location: One Madison Avenue, 17th Floor, New York, New York 10010 at 10:00 a.m. New York time
• ·Common Stock par value: $0.001 per share
• ·Fund fiscal year end: November 30
• ·Potential virtual/hybrid format changes to be announced via press release and EDGAR

09-03-2026

Western Asset Global Corporate Opportunity Fund Inc. (NYSE: GDO) issued a proxy statement for its annual stockholder meeting on April 17, 2026, at 10:00 a.m. ET in New York, NY, to elect three Class I Directors (Proposal 1) and ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending October 31, 2026 (Proposal 2). The record date is February 6, 2026, with 7,519,400 shares of common stock outstanding. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Meeting location: One Madison Avenue, 17th Floor, New York, New York 10010
• ·Quorum requires majority of outstanding shares present in person or by proxy
• ·Proxies default to 'FOR' both proposals unless otherwise instructed

09-03-2026

Fifth Third Bancorp's DEF 14A Proxy Statement for the 2026 Annual Meeting solicits votes for electing 16 directors to serve until the 2027 meeting, ratifying Deloitte & Touche LLP as independent auditors for 2026, and advisory approval of named executive officer compensation, with the Board recommending FOR all proposals. The virtual meeting is scheduled for April 21, 2026, at 11:30 a.m. ET, with record date February 24, 2026. Includes compensation disclosures via XBRL for PEOs Timothy N. Spence and Greg D. Carmichael across 2021-2025, focusing on equity awards adjustments and fair value changes.

• ·Annual Meeting: virtual only at www.virtualshareholdermeeting.com/FITB2026, starting 11:15 a.m. ET on April 21, 2026.
• ·Voting deadlines: 11:59 p.m. ET April 20, 2026 (direct Common Stock); April 16, 2026 (Plan stock and Series A Class B Preferred Stock).
• ·Proxy materials first available on or about March 9, 2026.
• ·Compensation tables cover 2021-2025 for PEO and Non-PEO NEOs, including equity awards, fair value changes, dividends on unvested awards, and adjustments.

09-03-2026

Kontoor Brands, Inc. (KTB) has issued its DEF 14A Proxy Statement for the 2026 Annual Meeting of Shareholders, to be held virtually on April 23, 2026, at 11:00 a.m. ET, covering election of six directors, ratification of PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending January 2, 2027, approval of named executive officer compensation on a non-binding basis, and a vote on the frequency of future Say-on-Pay votes (Board recommends 1 year). The record date is February 13, 2026, with 55,242,606 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.

• ·Annual Meeting registration required by April 22, 2026, at 5:00 p.m. ET via www.proxyvote.com using control number.
• ·Proxy materials available online at www.proxyvote.com since on or about March 9, 2026; printed copies available upon request.
• ·Fiscal year reference: ended January 3, 2026; next fiscal year ends January 2, 2027.

09-03-2026

Matson, Inc. issued its DEF 14A Proxy Statement dated March 9, 2026, for the 2026 Annual Meeting of Shareholders on April 23, 2026, at 8:30 a.m. HST in Honolulu, Hawaii, with a record date of February 20, 2026. Shareholders will vote on electing seven director nominees, an advisory approval of executive compensation, and ratification of Deloitte & Touche LLP as independent auditors for the year ending December 31, 2026. The filing uses the SEC's notice and access model for proxy materials.

• ·Annual Meeting location: 1411 Sand Island Parkway, Honolulu, Hawaii 96819.
• ·Proxy materials available at www.proxyvote.com.
• ·Shareholders attending must present admission ticket and government-issued photo ID, plus complete Request for Visitor Entry form.

09-03-2026

RTX Corporation filed its definitive proxy statement (DEF 14A) on March 9, 2026, ahead of its annual shareholder meeting on April 30, 2026. The filing discloses executive compensation details for Principal Executive Officers (PEO), including Christopher T. Calio and Gregory J. Hayes, covering compensation elements such as stock awards, option awards, pension benefits changes, and pay-versus-performance adjustments across years 2021-2025. No specific compensation amounts or performance metrics are provided in the excerpted metadata.

• ·Fiscal year end: December 31
• ·Company headquarters: 1000 Wilson Blvd, Arlington, VA 22209
• ·State of incorporation: Delaware
• ·SEC file number: 001-00812

09-03-2026

UFP Industries' 2026 Proxy Statement discloses 56,799,895 outstanding common shares as of February 27, 2026, with major beneficial owners including BlackRock Inc. (7,475,832 shares, 13.16%), The Vanguard Group (6,882,889 shares, 12.12%), and Kayne Anderson Rudnick Investment Management, LLC (3,746,737 shares, 6.60%). The Board nominates four directors—Mary Tuuk Kuras (two-year term), Benjamin J. McLean, Michael G. Wooldridge, and new nominee Ronald K. Grubbs, Jr. (three-year terms)—expanding the Board from eight to nine members ahead of the Annual Meeting. No financial performance metrics or period-over-period comparisons are provided.

• ·Record Date for Annual Meeting: February 27, 2026.
• ·Board nominees: Mary Tuuk Kuras for two-year term expiring 2028; Benjamin J. McLean, Michael G. Wooldridge, Ronald K. Grubbs, Jr. for three-year terms expiring 2029.
• ·Incumbent directors with terms expiring 2027: Matthew J. Missad, Thomas W. Rhodes, Brian C. Walker.
• ·BlackRock Schedule 13G/A filed April 28, 2025; Vanguard February 13, 2024; Kayne Anderson May 14, 2025.

09-03-2026

TriplePoint Venture Growth BDC Corp. (TPVG) filed a definitive proxy statement (DEF 14A) on March 9, 2026, for its 2026 Annual Meeting of Stockholders to be held virtually on April 29, 2026, at 10:00 a.m. PT via www.virtualshareholdermeeting.com/TPVG2026. Stockholders of record as of March 9, 2026, with 40,491,145 shares of common stock outstanding, will vote to elect three Class III directors serving until the 2029 annual meeting and ratify Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026. No financial performance data or period comparisons are provided in the filing.

• ·Annual Meeting quorum requires majority of votes entitled to be cast on record date.
• ·Proxy materials and 2025 Form 10-K available at www.proxyvote.com.
• ·Written requests to attend webcast at Dechert LLP offices due by April 22, 2026.

09-03-2026

Cumberland Pharmaceuticals Inc. (CPIX) has issued a proxy statement for its 2026 Annual Meeting on April 21, 2026, at 9:30 a.m. CT in Nashville, TN, to elect two Class I directors (Kenneth J. Krogulski and Caroline Young for terms expiring 2029), ratify Carr, Riggs & Ingram, L.L.C. as independent auditors for the year ending December 31, 2026, approve executive compensation on an advisory basis, and vote on the frequency of future say-on-pay votes (Board recommends every three years). Shareholders of record as of February 27, 2026, from 15,878,836 outstanding common shares (quorum at 7,939,419 shares), can vote in person, by internet, mobile, or mail. No financial performance metrics or period comparisons are detailed in the filing.

• ·Board consists of seven directors divided into three classes with staggered three-year terms; two Class I seats up for election.
• ·Voting: Plurality for directors; majority of votes cast for other proposals; abstentions not counted as votes cast (except directors).
• ·Broker non-votes count for quorum but not for non-routine matters (Proposals I, III, IV).
• ·Proxy materials available online at http://www.cstproxy.com/cumberlandpharma/2026; Notice mailed March 12, 2026.

09-03-2026

Shenandoah Telecommunications Company's (Shentel) DEF 14A proxy statement, filed March 9, 2026, outlines the April 21, 2026 annual shareholder meeting to elect three Class 1 directors (Matthew S. DeNichilo, Kenneth L. Quaglio, Michael A. Rhymes) for terms expiring in 2029, ratify RSM US LLP as independent auditors for 2026, and approve named executive officer compensation on an advisory basis. The Board highlights strong governance with 90.90% independence (CEO as sole management director), 36% female/minority representation, majority voting for directors, and policies prohibiting share hedging. Record date is February 23, 2026; no performance declines or flat metrics are disclosed in this governance-focused filing.

• ·Annual meeting location: 500 Shentel Way, Edinburg, Virginia 22824 at 11:00 a.m. Eastern Time
• ·Proxy materials and Form 10-K available at www.proxyvote.com
• ·All Board committees consist solely of independent directors

09-03-2026

NeuroOne Medical Technologies Corporation's 2026 Annual Meeting is scheduled for April 3, 2026, at 9:00 a.m. in Eden Prairie, MN, with stockholders of record as of February 20, 2026 (50,693,017 shares outstanding) voting on electing two Class III directors, ratifying Baker Tilly US, LLP as independent auditors, approving a reverse stock split (1-for-2 to 1-for-15) to comply with Nasdaq listing requirements, amending the 2025 Equity Incentive Plan, and authorizing adjournments for the reverse split if needed. The reverse split proposal signals potential non-compliance with Nasdaq standards, posing a risk to listing status, while other items are routine governance matters.

• ·Quorum requires one third of outstanding shares present in person or by proxy.
• ·Proposal 1 (director election) approved by plurality; Proposals 2, 4, 5 by majority of shares present and entitled to vote; Proposal 3 (reverse split) by majority of votes cast.
• ·Proxies must be received by 11:59 p.m. ET on April 1, 2026, if submitted via Internet or telephone.

09-03-2026

Park National Corporation (PRK) filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Shareholders, scheduled virtually on April 27, 2026, at 2:00 p.m. EDT. Key proposals include electing four director nominees, an advisory vote to approve named executive officer compensation, ratifying Crowe LLP as independent auditors for the fiscal year ending December 31, 2026, and approving the 2026 Long-Term Incentive Plans for employees and non-employee directors. The filing includes XBRL-tagged disclosures on executive compensation elements such as equity awards and pension adjustments for the PEO and non-PEO NEOs across 2021-2025, though specific values are not detailed in the provided content.

• ·Annual Meeting virtual access: www.virtualshareholdermeeting.com/PRK2026
• ·Meeting location reference: 51 North Third Street, Post Office Box 3500, Newark, Ohio 43058-3500
• ·Fiscal year for auditor ratification: ending December 31, 2026
• ·Compensation disclosures cover PEO and non-PEO NEOs for years 2021-2025

09-03-2026

Deluxe Corporation highlighted strong 2025 performance with Payments and Data businesses growing 10% YoY to comprise 47% of revenue (up from 43%), offsetting secular declines in the legacy Print segment, while comparable adjusted EBITDA rose over 6% and adjusted EPS over 10% YoY. Free cash flow exceeded the $100M incremental run-rate target for 2026 a year early, reducing leverage to 3.2x. The proxy statement seeks shareholder approval for electing nine directors, advisory vote on executive compensation, Amendment No. 3 to the 2022 Stock Incentive Plan, and ratification of PricewaterhouseCoopers LLP as auditor at the virtual annual meeting on April 23, 2026.

• ·Record date: February 23, 2026
• ·S&P upgraded rating twice in 2025
• ·Comparable adjusted EBITDA growing YoY for 12 consecutive quarters
• ·Profits grew faster than revenue for third consecutive year
• ·Cheryl E. Mayberry McKissack retiring, not standing for reelection
• ·Board composition post-meeting: 33% female, 22% ethnic/racial diversity, average tenure 5.1 years
• ·Investor Day goals set December 2023

09-03-2026

eXp World Holdings, Inc. (EXPI) filed its definitive proxy statement (DEF 14A) on March 9, 2026, for the annual stockholder meeting on April 24, 2026, at 12:00 p.m. ET virtually. Proposals include election of six directors, ratification of Deloitte & Touche LLP as independent auditor for 2026, advisory vote on 2025 named executive officer compensation, and approval of redomestication from Delaware to Texas by conversion, requiring majority statutory and unaffiliated stockholder approval. As of record date February 27, 2026, 206,004,197 shares issued with 46,735,783 treasury shares, leaving 159,268,414 outstanding shares entitled to vote.

• ·Annual meeting quorum requires majority of 159,268,414 outstanding shares.
• ·Abstentions treated as votes against for Proposal 4 statutory approval but no effect on unaffiliated approval.
• ·Voting deadline: 11:59 p.m. ET on April 23, 2026 via internet or mail; live at meeting on April 24, 2026.

09-03-2026

Eagle Bancorp Montana, Inc. issued a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders on April 23, 2026, at 11:00 a.m. MT, proposing the election of four director nominees for three-year terms (Samuel D. Waters, Cynthia A. Utterback, Corey I. Jensen, Tanya J. Chemodurow), ratification of Plante & Moran, PLLC as independent auditors for the fiscal year ending December 31, 2026, and an advisory vote on named executive officer compensation. The record date is March 6, 2026, with 7,965,431 shares of common stock outstanding, requiring a majority quorum. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Voting methods: Internet (www.investorvote.com/EBMT), telephone (1-800-652-8683), mail, or in person
• ·Proxy revocation deadline: 11:59 p.m. MT on April 22, 2026
• ·Proposal 1 (director election) is non-routine; Proposal 2 (auditor ratification) is routine; Proposal 3 (say-on-pay) is non-routine
• ·Directors elected by plurality vote; other proposals require majority of shares present and entitled to vote

09-03-2026

Moleculin Biotech, Inc. is seeking shareholder approval for the Nasdaq Proposal to make exercisable 6,367,956 Series H Warrants issued on February 20, 2026, potentially generating $15.3M in proceeds upon full cash exercise at $2.3976 per share, but resulting in significant dilution as these shares represent about 129% of the current 4,933,110 outstanding shares. The proxy also proposes changing the company name to Moleculin Inc. and authorizes adjournment if needed to solicit more votes. Directors and executives as a group beneficially own only 1.1% of shares as of February 20, 2026.

• ·Warrant exercise price: $2.3976 (floor $0.962); 5-year term post-approval.
• ·Resale Registration Statement to be filed by March 31, 2026; effective by April 30, 2026.
• ·Lock-up on new issuances until later of 65 days from Feb 19, 2026, shareholder approval, or registration effective date.
• ·Individual director/executive ownership: all less than 1% (e.g., Walter V. Klemp: 34,653 shares).

09-03-2026

LMP Capital and Income Fund Inc. (NYSE: SCD) issued a definitive proxy statement for its Annual Meeting of Stockholders on April 17, 2026, seeking approval to elect three Class III Directors and ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending November 30, 2026. The record date is February 6, 2026, with 22,906,336 shares of common stock outstanding. No financial performance data, period comparisons, or material updates are disclosed.

• ·Annual Meeting location: One Madison Avenue, 17th Floor, New York, New York 10010 at 10:00 a.m. New York time
• ·Fiscal year end: November 30
• ·Common Stock par value: $0.001 per share
• ·Fund subject to Maryland Control Share Acquisition Act (MCSAA)

09-03-2026

Western Asset Diversified Income Fund (NYSE: WDI) has issued a proxy statement for its Annual Meeting of Shareholders on April 17, 2026, at 10:00 a.m. New York time, to elect two Class II Trustees (Proposal 1) and ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2026 (Proposal 2). The record date is February 6, 2026, with 51,912,116 common shares outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are disclosed.

• ·Meeting location: One Madison Avenue, 17th Floor, New York, New York 10010
• ·Common shares par value: $0.001 per share
• ·Proxy materials available on or about March 9, 2026

09-03-2026

Western Asset Municipal High Income Fund Inc. (MHF) issued a proxy statement for its Annual Meeting of Stockholders on April 17, 2026, at 10:00 a.m. New York time, to elect three Class III Directors (Proposal 1) and ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending October 31, 2026 (Proposal 2). The record date is February 6, 2026, with 22,206,849 shares of common stock outstanding. No financial performance data, period comparisons, or other metrics are provided in the filing.

• ·Meeting location: One Madison Avenue, 17th Floor, New York, New York 10010
• ·Fund's investment adviser: Franklin Templeton Fund Adviser, LLC (FTFA); subadviser: Western Asset Management Company, LLC
• ·Fund organized as Maryland corporation and registered investment company
• ·Quorum requires majority of outstanding shares; abstentions and broker non-votes count for quorum but not votes

09-03-2026

ClearBridge Energy Midstream Opportunity Fund Inc. (EMO) issued a proxy statement for its Annual Meeting of Stockholders on April 17, 2026, at 10:00 a.m. in New York, NY, to elect two Class III Directors by common and preferred shares voting together and one Class III Director by preferred shares, and to ratify PricewaterhouseCoopers LLP as auditors for the fiscal year ending November 30, 2026. The record date is February 6, 2026, with 20,014,627 common shares (par value $0.001) and 1,948,579 preferred shares (liquidation preference $35 per share) outstanding. No financial performance metrics or period-over-period comparisons are provided.

• ·Meeting may be virtual/hybrid with updates via press release on www.franklintempleton.com/investments/options/closed-end-funds
• ·Quorum requires majority of outstanding common and preferred shares voting together
• ·Directors elected by majority vote; auditor ratification by majority of votes cast

09-03-2026

BrandywineGLOBAL - Global Income Opportunities Fund Inc. (BWG) has issued a proxy statement for its Annual Meeting of Stockholders on April 17, 2026, at 10:00 a.m. New York time, to elect three Class II Directors (Proposal 1) and ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending October 31, 2026 (Proposal 2). The record date is February 6, 2026, with 16,791,836 shares of common stock and 2,500,000 Series E Preferred Shares outstanding as of that date. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Meeting location: One Madison Avenue, 17th Floor, New York, New York 10010
• ·Fund is a Maryland corporation and registered investment company
• ·Subject to Maryland Control Share Acquisition Act (MCSAA)

09-03-2026

Citizens Financial Group, Inc. (CFG) filed its 2026 definitive proxy statement ahead of the April 23, 2026 annual shareholder meeting, seeking approval to elect 12 directors, an advisory vote on executive compensation, ratification of Deloitte & Touche LLP as auditors for fiscal 2026, and a shareholder proposal for a majority voting standard. As of December 31, 2025, the company reported $226.4B in assets, $183.3B in deposits, and $142.7B in loans and leases, with 2025 performance described as strong, including top peer group share price appreciation despite market uncertainty. Leadership highlighted the Reimagine the Bank initiative and colleague volunteerism of nearly 267,000 hours, while noting director Bill Hankowsky's retirement after 19 years.

• ·Annual meeting record date: February 27, 2026
• ·Director Bill Hankowsky retiring after 19 years of service
• ·Shareholder proposal requests adoption of majority voting standard for director elections